Skip to main content
MyCapitol LogoMyCapitol

HR 8205 · 119th Congress

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

This bill extends a program designed to speed up the development and approval of treatments for ALS (amyotrophic lateral sclerosis), a serious neurodegenerative disease that affects nerve cells in the brain and spinal cord. The original program was set to expire in 2026, but this bill keeps it running through 2031,…

Sponsor
Quigley, Mike (D-Illinois)
Introduced
2026-04-06
Policy area
Health
Latest action
Became Public Law No: 119-138.

Digging through Congress... 🔍